Gene therapy: A promising approach for breast cancer treatment

Niloufar Tavakoli Dastjerd1, Ali Valibeik2, Sobhan Rahimi Monfared2

  • 1Department of Medical Biotechnology, School of Allied Medical Sciences, Qazvin University of Medical Sciences, Qazvin, Iran.

Insights

Gene therapy offers a promising, less toxic alternative for breast cancer (BC) treatment by targeting tumor cells genetically. This review explores BC gene therapy strategies, challenges, and recent advancements.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biotechnology

Background:

  • Breast cancer (BC) is a leading global cancer in women, necessitating novel therapeutic strategies beyond traditional treatments due to their side effects.
  • Advancements in understanding BC's molecular basis have paved the way for gene therapy as a potentially more effective and targeted treatment modality.
  • Gene therapy aims to correct, add, or suppress genes within target cells, offering a new frontier in cancer treatment.

Purpose of the Study:

  • To provide a comprehensive review of gene therapy approaches for breast cancer.
  • To discuss the current limitations, challenges, and recent progress in the field of BC gene therapy.
  • To highlight the potential of gene therapy as a less toxic alternative to conventional breast cancer treatments.

Main Methods:

  • Review of existing literature on breast cancer molecular biology and gene therapy.
  • Analysis of clinical trial data regarding the efficacy and toxicity of gene therapy for BC.
  • Synthesis of information on various gene therapy strategies, vectors, and delivery systems.
  • Examination of challenges related to targeting tumor cells specifically and overcoming biological barriers.

Main Results:

  • Gene therapy demonstrates potential for targeted treatment of breast cancer cells, minimizing harm to healthy tissues.
  • Clinical studies indicate that gene therapy approaches for BC are associated with reduced toxicity compared to traditional therapies.
  • Significant research efforts are ongoing to refine gene therapy techniques and address existing challenges.

Conclusions:

  • Gene therapy represents a significant advancement in breast cancer treatment, offering a more targeted and less toxic therapeutic option.
  • Continued research and clinical trials are crucial for optimizing gene therapy strategies and overcoming current limitations for widespread clinical application.
  • The future of breast cancer management may increasingly involve sophisticated gene therapy interventions.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
26.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
554